Methylphenidate-associated chest pain in a child
A young child was diagnosed with autism spectrum disorder with comorbid attention-deficit/hyperactivity disorder. His hyperactivity, impulsivity and absence of awareness towards danger increased his risk of harm and hence methylphenidate was indicated. Unfortunately, he developed chest pain eight mo...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Published: |
BMJ Publishing Group
2023
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/109366/ |
| _version_ | 1848865352483602432 |
|---|---|
| author | Masiran, Ruziana Ilias, Mohamad Nizam Adha Yubbu, Putri |
| author_facet | Masiran, Ruziana Ilias, Mohamad Nizam Adha Yubbu, Putri |
| author_sort | Masiran, Ruziana |
| building | UPM Institutional Repository |
| collection | Online Access |
| description | A young child was diagnosed with autism spectrum disorder with comorbid attention-deficit/hyperactivity disorder. His hyperactivity, impulsivity and absence of awareness towards danger increased his risk of harm and hence methylphenidate was indicated. Unfortunately, he developed chest pain eight months after the treatment initiation. We then stopped the stimulant and changed his treatment to atomoxetine, after which he no longer had chest pain. In the following illustrated case, we will discuss the cardiac side effect of methylphenidate. |
| first_indexed | 2025-11-15T14:03:21Z |
| format | Article |
| id | upm-109366 |
| institution | Universiti Putra Malaysia |
| institution_category | Local University |
| last_indexed | 2025-11-15T14:03:21Z |
| publishDate | 2023 |
| publisher | BMJ Publishing Group |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | upm-1093662024-08-05T03:27:35Z http://psasir.upm.edu.my/id/eprint/109366/ Methylphenidate-associated chest pain in a child Masiran, Ruziana Ilias, Mohamad Nizam Adha Yubbu, Putri A young child was diagnosed with autism spectrum disorder with comorbid attention-deficit/hyperactivity disorder. His hyperactivity, impulsivity and absence of awareness towards danger increased his risk of harm and hence methylphenidate was indicated. Unfortunately, he developed chest pain eight months after the treatment initiation. We then stopped the stimulant and changed his treatment to atomoxetine, after which he no longer had chest pain. In the following illustrated case, we will discuss the cardiac side effect of methylphenidate. BMJ Publishing Group 2023-11-27 Article PeerReviewed Masiran, Ruziana and Ilias, Mohamad Nizam Adha and Yubbu, Putri (2023) Methylphenidate-associated chest pain in a child. BMJ Case Reports, 16 (11). art. no. e255187. pp. 1-4. ISSN 1757-790X https://casereports.bmj.com/content/16/11/e255187 10.1136/bcr-2023-255187 |
| spellingShingle | Masiran, Ruziana Ilias, Mohamad Nizam Adha Yubbu, Putri Methylphenidate-associated chest pain in a child |
| title | Methylphenidate-associated chest pain in a child |
| title_full | Methylphenidate-associated chest pain in a child |
| title_fullStr | Methylphenidate-associated chest pain in a child |
| title_full_unstemmed | Methylphenidate-associated chest pain in a child |
| title_short | Methylphenidate-associated chest pain in a child |
| title_sort | methylphenidate-associated chest pain in a child |
| url | http://psasir.upm.edu.my/id/eprint/109366/ http://psasir.upm.edu.my/id/eprint/109366/ http://psasir.upm.edu.my/id/eprint/109366/ |